Stay updated on Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.

Latest updates to the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRemoved the disease term 'Multiple Myeloma' and related topics, along with the MedlinePlus Genetics reference. This changes the page's disease-focused context and available genetics resources.SummaryDifference0.2%

- Check16 days agoChange DetectedNew topic tags were added to reflect the study's disease area and related resources (Multiple myeloma and MedlinePlus Genetics). The site revision was updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check23 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's template or underlying system.SummaryDifference0.1%

- Check30 days agoChange DetectedThe MedlinePlus-related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics'. This removes certain consumer health resource links from the related topics area, affecting navigation but not the study content.SummaryDifference0.2%

- Check38 days agoChange DetectedAdded navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and metadata fields (Last verified, Last known status), and updated the revision tag from v3.5.5 to v3.6.0. Reformatted the Interventions section label from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference1%

- Check45 days agoChange DetectedThe revision label changed from v3.5.4 to v3.5.5, representing a small update to the page’s published version. This reflects an incremental update to the page’s version rather than content changes.SummaryDifference0.1%

Stay in the know with updates to Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.